[1]蒋冠华,张勇勤,崔娜,等.老年肌少症及其合并症的营养干预研究进展[J].新乡医学院学报,2023,40(12):1184-1190.[doi:10.7683/xxyxyxb.2023.12.016]
 JIANG Guanhua,ZHANG Yongqin,CUI Na,et al.Research progress on nutritional intervention in elderly sarcopenias and its complications[J].Journal of Xinxiang Medical University,2023,40(12):1184-1190.[doi:10.7683/xxyxyxb.2023.12.016]
点击复制

老年肌少症及其合并症的营养干预研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年12
页码:
1184-1190
栏目:
综述
出版日期:
2023-12-05

文章信息/Info

Title:
Research progress on nutritional intervention in elderly sarcopenias and its complications
作者:
蒋冠华1张勇勤12崔娜1周一帆1张世远1江英婵1张琦1
(1.河南中医药大学护理学院,河南 郑州 450046;2.河南中医药大学第一附属医院护理部,河南 郑州 450000)
Author(s):
JIANG Guanhua1ZHANG Yongqin12CUI Na1ZHOU Yifan1ZHANG Shiyuan1JIANG Yingchan1ZHANG Qi1
(1.School of Nursing,Henan University of Chinese Medicine,Zhengzhou 450046,Henan Province,China;2.Department of Nursing,the First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,Henan Province,China)
关键词:
老年人肌少症营养干预
Keywords:
elderlysarcopenianutritional intervention
分类号:
R685
DOI:
10.7683/xxyxyxb.2023.12.016
文献标志码:
A
摘要:
肌少症又称“少肌症”“肌肉减少症”“肌肉衰减症”,是一种以与年龄相关的肌肉质量下降、肌肉力量和功能衰退为主要特点的老年综合征,其可增加患者身体残疾、生活质量差和死亡等不良后果风险。肌少症的发病因素主要包括高龄、疾病、缺乏运动、营养不良等,而机体营养状况作为影响肌少症的关键因素之一,在肌少症发生发展中起重要作用。本文就营养在肌少症中的作用,以及常见慢性疾病合并肌少症患者的营养干预进行综述,旨在为老年肌少症患者制定更加科学、合理的营养干预方案提供依据。
Abstract:
Sarcopenia,also known as "oligomyositis" "hypomyositis" and "muscle wasting",is an age-related geriatric syndrome characterized by decreased muscle mass,muscle strength and function decline.It can increase the risk of adverse outcomes such as physical disability,poor quality of life,and death.The pathogenic factors of sarcopenia mainly include older age,diseases,lack of exercise,malnutrition,etc.As one of the key factors affecting sarcopenia,the nutritional status of the body play an important role in the development of sarcopenia.Therefore,this paper reviews the role of nutrition in sarcopenia and nutritional interventions for patients with common chronic diseases combined with sarcopenia,aiming to provide a basis for the developing more scientific and rationalized nutritional intervention program for elderly patients with sarcopenia.

参考文献/References:

[1] CRUZ-JENTOFT A J,SAYER A A.Sarcopenia[J].Lancet,2019,393(10191):2636-2646.
[2] 刘娟,丁清清,周白瑜,等.中国老年人肌少症诊疗专家共识(2021)[J].中华老年医学杂志,2021,40(8):943-952.
LIU J,DING Q Q,ZHOU B Y,et al.Chinese expert consensus on diagnosis and treatment for elderly with sarcopenia(2021)[J].Chin J Geriatr,2021,40(8):943-952.
[3] CHEN L K,WOO J,ASSANTACHAI P,et al.Asian working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307.
[4] TEN HAAF D S M,EIJSVOGELS T M H,BONGERS C C C W G,et al.Protein supplementation improves lean body mass in physically active older adults:a randomized placebo-controlled trial[J].J Cachexia Sarcopenia Muscle,2019,10(2):298-310.
[5] VERLAAN S,MAIER A B,BAUER J M,et al.Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults:the PROVIDE study[J].Clin Nutr,2018,37(2):551-557.
[6] LATTANZI B,BRUNI A,DI COLA S,et al.The effects of 12-week beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis:results from a randomized controlled single-blind pilot study[J].Nutrients,2021,13(7):2296.
[7] ROSENBERG I H.Sarcopenia:origins and clinical relevance[J].Clin Geriatr Med,2011,27(3):337-339.
[8] CRUZ-JENTOFT A J,BAEYENS J P,BAUER J M,et al.Sarcopenia:european consensus on definition and diagnosis:report of the european working group on sarcopenia in older people[J].Age Ageing,2010,39(4):412-423.
[9] SMITH C,WOESSNER M N,SIM M,et al.Sarcopenia definition:does it really matter? Implications for resistance training[J].Ageing Res Rev,2022,78:101617.
[10] 石婧,陈术强,高超,等.预防老年人肌少症核心信息解读[J].中华老年医学杂志,2021,40(8):955-957.
SHI J,CHEN S Q,GAO C,et al.Special topic on sarcopenia in the elderly Interpretation of core information on sarcopenia prevention in the elderly[J].Chin J Geriatr,2021,40(8):955-957.
[11] LIU J C,DONG S S,SHEN H,et al.Multi-omics research in sarcopenia:current progress and future prospects[J].Ageing Res Rev,2022,76:101576.
[12] 钟静,王秀华.老年人肌少症非药物干预的研究进展[J].中国护理管理,2019,19(8):1256-1262.
ZHONG J,WANG X H.Research progress on non-pharmacological interventions for sarcopenia in the elderly[J].Chin Nurs Manag,2019,19(8):1256-1262.
[13] 孙建琴,张坚,常翠青,等.肌肉衰减综合征营养与运动干预中国专家共识(节录)[J].营养学报,2015,37(4):320-324.
SUN J Q,ZHANG J,CHANG C Q,et al.Consensus of Chinese experts on nutrition and exercise intervention for sarcopenia(excerpt)[J].Acta Nutrimenta Sinica,2015,37(4):320-324.
[14] PUTRA C,KONOW N,GAGE M,et al.Protein source and muscle health in older adults:a literature review[J].Nutrients,2021,13(3):743.
[15] PARK Y,CHOI J E,HWANG H S.Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects:a randomized,double-blind,placebo-controlled trial[J].Am J Clin Nutr,2018,108(5):1026-1033.
[16] LIN C C,SHIH M H,CHEN C D,et al.Effects of adequate dietary protein with whey protein,leucine,and vitamin D supplementation on sarcopenia in older adults:an open-label,parallel-group study[J].Clin Nutr,2021,40(3):1323-1329.
[17] CEREDA E,PISATI R,RONDANELLI M,et al.Whey protein,leucine- and vitamin-D-enriched oral nutritional supplementation for the treatment of sarcopenia[J].Nutrients,2022,14(7):1524.
[18] CARLBERG C,HAQ A.The concept of the personal vitamin D response index[J].J Steroid Biochem Mol Biol,2018,175:12-17.
[19] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
XIA W B,ZHANG Z H,LIN H,et al.Guidelines for the diagnosis and management of primary osteoporosis (2017)[J].Chin J Osteoporos,2019,25(3):281-309.
[20] REMELLI F,VITALI A,ZURLO A,et al.Vitamin D deficiency and sarcopenia in older persons[J].Nutrients,2019,11(12):2861.
[21] KSI Z·EK A,ZAGRODNA A,SOWISKA-LISOWSKA M.Vitamin D,skeletal muscle function and athletic performance in athletes-a narrative review[J].Nutrients,2019,11(8):1800.
[22] KNUTSEN K V,BREKKE M,GJELSTAD S,et al.Vitamin D status in patients with musculoskeletal pain,fatigue and headache:a cross-sectional descriptive study in a multi-ethnic general practice in Norway[J].Scand J Prim Health Care,2010,28(3):166-171.
[23] 中国老年保健医学研究会老龄健康服务与标准化分会.老年人维生素D营养素强化补充规范共识[J].中国老年保健医学,2019,17(4):42-45.
AGEING HEALTH SERVICE AND STANDARDIZATION BRANCH OF CHINESE ASSOCIATION OF GERIATRIC RESEARCH.Consensus on the regulation of vitamin D supplementation for the elderly[J].Chin J Geriatr Care,2019,17(4):42-45.
[24] BODE L E,MCCLESTER B M,HAWES E M.Vitamin D supplementation for extraskeletal indications in older persons[J].J Am Med Dir Assoc,2020,21(2):164-171.
[25] CRUZ-JENTOFT A J.Beta-Hydroxy-beta-methyl butyrate(HMB):from experimental data to clinical evidence in sarcopenia[J].Curr Protein Pept Sci,2018,19(7):668-672.
[26] OKTAVIANA J,ZANKER J,VOGRIN S,et al.The effect of β-hydroxy-β-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons:a systematic review[J].J Nutr Health Aging,2019,23(2):145-150.
[27] 左丹,黄彪,罗春丽,等.β-羟基-β-甲基丁酸口服补充对髋部骨折老年患者的影响[J].肿瘤代谢与营养电子杂志,2019,6(4):462-467.DOI:10.16689/j.cnki.cnll-9349/r.2019.04.014.
ZUO D,HUANG B,LUO C L,et al.Effect of oral supplement ofβ-hydroxy-β-methylbutyric acid on elderly patients with hip fracture[J].Electron J Metab Nutr Cancer,2019,6(4):462-467.DOI:10.16689/j.cnki.cnll-9349/r.2019.04.014.
[28] 陈伟,李增宁,许红霞,等.特殊医学用途配方食品(FSMP)临床管理专家共识(2021版)[J].中国医疗管理科学,2021,11(4):91-96.
CHEN W,LI Z N,XU H X,et al.Expert consensus on clinical management of food for special medical purposes (FSMP) (2021 edition)[J].Chin J Med Manag Sci,2021,11(4):91-96.
[29] BAIU I,SPAIN D A.Enteral nutrition[J].JAMA,2019,321(20):2040.
[30] 岳庆峰,魏祥志.食管癌病人手术后早期肠内营养研究进展[J].肠外与肠内营养,2016,23(2):120-123.
YUE Q F,WEI X Z.Review of early enteral nutrition after esophageal cancer surgery[J].Parenter Enteral Nutr,2016,23(2):120-123.
[31] KITA R,MIYATA H,SUGIMURA K,et al.Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer[J].Clin Nutr,2021,40(6):4380-4385.
[32] 石汉平,王晓琳,杨韵.临床营养若干名词解析[J].肿瘤代谢与营养电子杂志,2019,6(2):155-160.DOI:10.16689/j.cnki.cnll-9349/r.2019.02.001.
SHI H P,WANG X L,YANG Y.The explanations on several terms of clinical nutrition[J].Electron J Metab Nutr Cancer,2019,6(2):155-160.DOI:10.16689/j.cnki.cnll-9349/r.2019.02.001.
[33] 王秋梅,刘晓红,张片红,等.肠内营养制剂和乳清蛋白对老年人肌肉质量和功能的影响[J].中华老年医学杂志,2016,35(8):862-866.
WANG Q M,LIU X H,ZHANG P H,et al.Effects of enteral nutrition and lactalbumin on muscle mass and function in the elderly[J].Chin J Geriatr,2016,35(8):862-866.
[34] CEDERHOLM T,BARAZZONI R,AUSTIN P,et al.ESPEN guidelines on definitions and terminology of clinical nutrition[J].Clin Nutr,2017,36(1):49-64.
[35] MALAFARINA V,URIZ-OTANO F,MALAFARINA C,et al.Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients.A multi-centre randomized trial[J].Maturitas,2017,101:42-50.
[36] WANG J,TAN S,WU G.Oral nutritional supplements,physical activity,and sarcopenia in cancer[J].Curr Opin Clin Nutr Metab Care,2021,24(3):223-228.
[37] 臧华龙,秦学祥,翁敏.口服营养补充剂对维持性血液透析病人肌少症及生存质量的影响[J].肠外与肠内营养,2018,25(6):349-354.
ZANG H L,QIN X X,WENG M.Effects of oral nutritional supplements on sarcopenia andquality of life in maintenance hemodialysis patients[J].Parenter Enter Nutr,2018,25(6):349-354.
[38] CHEW S T H,TAN N C,CHEONG M,et al.Impact of specialized oral nutritional supplement on clinical,nutritional,and functional outcomes:a randomized,placebo-controlled trial in community-dwelling older adults at risk of malnutrition[J].Clin Nutr,2021,40(4):1879-1892.
[39] LIU C,CHEUNG W H,LI J,et al.Understanding the gut microbiota and sarcopenia:a systematic review[J].J Cachexia Sarcopenia Muscle,2021,12(6):1393-1407.
[40] GROSICKI G J,FIELDING R A,LUSTGARTEN M S.Gut microbiota contribute to age-related changes in skeletal muscle size,composition,and function:biological basis for a gut-muscle axis[J].Calcif Tissue Int,2018,102(4):433-442.
[41] REN X,HAO S,YANG C,et al.Alterations of intestinal microbiota in liver cirrhosis with muscle wasting[J].Nutrition,2021,83:111081.
[42] ABIRI B,VAFA M.Nutrition and sarcopenia:a review of the evidence of nutritional influences[J].Crit Rev Food Sci Nutr,2019,59(9):1456-1466.
[43] PAPADOPOULOU S K.Sarcopenia:a contemporary health problem among older adult populations[J].Nutrients,2020,12(5):1293.
[44] GANAPATHY A,NIEVES J W.Nutrition and sarcopenia:what do we know?[J].Nutrients,2020,12(6):1755.
[45] PETERMANN-ROCHA F,CHEN M,GRAY S R,et al.Factors associated with sarcopenia:a cross-sectional analysis using UK Biobank[J].Maturitas,2020,133:60-67.
[46] 梁清月,王仲,刘戎,等.加减八珍汤联合营养支持治疗老年骨骼肌减少症疗效观察[J].中国中西医结合杂志,2019,39(7):821-825.
LIANG Q Y,WANG Z,LIU R,et al.Clinical effect of modified bazhen decoction combined with nutrition support on elderly sarcopenla[J].CJITWM,2019,39(7):821-825.
[47] 任璇璇,姚惠,汪涛.八珍汤联合基础干预治疗老年肌少症临床疗效观察[J].中国现代医生,2016,54(16):127-130.
REN X X,YAO H,WANG T.Clinical effect observation of Bazhen soap combined with basic intervention in the treatment of elderly sarcopenia[J].China Mod Doct,2016,54(16):127-130.
[48] ANAGNOSTIS P,GKEKAS N K,ACHILLA C,et al.Type 2 diabetes mellitus is associated with increased risk of sarcopenia:a systematic review and meta-analysis[J].Calcif Tissue Int,2020,107(5):453-463.
[49] 何清华,孙明晓,岳燕芬,等.老年糖尿病肌少症患者的代谢特点及膳食分析[J].中华老年医学杂志,2019,42(5):552-557.
HE Q H,SUN M X,YUE Y F,et al.Analysis of dietary and metabolic characteristics in elderly sarcopenia patients with diabetes mellitus[J].Chin J Geriatr,2019,42(5):552-557.
[50] LEENDERS M,VERDIJK L B,HOEVEN L,et al.Patients with type 2 diabetes show a greater decline in muscle mass,muscle strength,and functional capacity with aging[J].J Am Med Dir Associ,2013,14(8):585-592.
[51] TAKAHASHI F,HASHIMOTO Y,KAJI A,et al.Association between geriatric nutrition risk index and the presence of sarcopenia in people with type 2 diabetes mellitus:a cross-sectional study[J].Nutrients,2021,13(11):3729.
[52] TANTAI X,LIU Y,YEO Y H,et al.Effect of sarcopenia on survival in patients with cirrhosis:a meta-analysis[J].J Hepatol,2022,76(3):588-599.
[53] BUNCHORNTAVAKUL C,REDDY K R.Review article:malnutrition/sarcopenia and frailty in patients with cirrhosis[J].Aliment Pharmacol Ther,2020,51(1):64-77.
[54] HSU C S,KAO J H.Sarcopenia and chronic liver diseases[J].Expert Rev Gastroenterol Hepatol,2018,12(12):1229-1244.
[55] 中华医学会肝病学分会.终末期肝病临床营养指南[J].中华肝脏病杂志,2019,27(5):330-342.
CHINESE SOCIETY OF HEPATOLOGY,CHINESE MEDICAL ASSOCIATION;CHINESE SOCIETY OF GASTROENTEROLOGY,CHINESE MEDICAL ASSOCIATION.Clinical guidelines on nutrition in end-stage liver disease[J].Chin J Hepatol,2019,27(5):330-342.
[56] KITAJIMA Y,TAKAHASHI H,AKIYAMA T,et al.Supplementation with branched-chain amino acids ameliorates hypoalbuminemia,prevents sarcopenia,and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis[J].J Gastroenterol,2018,53(3):427-437.
[57] KALU Z'NIAK-SZYMANOWSKA A,KRZYMI N'SKA-SIEMASZKO R,DESKUR-S'MIELECKA E,et al.Malnutrition,sarcopenia,and malnutrition-sarcopenia syndrome in older adults with COPD[J].Nutrients,2021,14(1):44.
[58] NGUYEN H T,COLLINS P F,PAVEY T G,et al.Nutritional status,dietary intake,and health-related quality of life in outpatients with COPD[J].Int J Chron Obstruct Pulmon Dis,2019,14:215-226.
[59] 吴丹,陈强谱.慢性阻塞性肺疾病相关肌少症的诊断与治疗[J].肠外与肠内营养,2021,28(5):308-312.
WU D,CHEN Q P.Diagnosis and treatment of chronic obstructive pulmonary disease-related sarcopenia[J].Parenter Enter Nutr,2021,28(5):308-312.
[60] HOLE C~EK M.Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions[J].J Cachexia Sarcopenia Muscle,2017,8(4):529-541.
[61] GIGLIO J,KAMIMURA M A,LAMARCA F,et al.Association of sarcopenia with nutritional parameters,quality of life,hospitalization,and mortality rates of elderly patients on hemodialysis[J].J Ren Nutr,2018,28(3):197-207.
[62] LI C,CHEN L,HE L,et al.Study on the relationship between sarcopenia and its components and anorexia in elderly maintenance haemodialysis patients[J].Nurs Open,2022,9(2):1096-1104.
[63] 杜晓菊,张海林,郭桂.维持性血液透析病人肌少症的研究进展[J].护理研究,2021,35(7):1194-1198.
DU X J,ZHANG H L,GUO G.Research progress of sarcopenia in maintenance hemodialysis patients[J].Chin Nurs Res,2021,35(7):1194-1198.
[64] 何艳芳,李琼香,翁敏.口服营养补充对维持性血液透析病人营养状况的疗效分析[J].肠外与肠内营养,2019,26(2):79-82.
HE Y F,LI Q X,WONG M.Effect of supplemental oral nutrition on nutritional status in patients receiving maintenance hemodialysis[J].Parenter Enter Nutr,2019,26(2):79-82.
[65] CURTIS A R,LIVINGSTONE K M,DALY R M,et al.Associations between dietary patterns and malnutrition,low muscle mass and sarcopenia in adults with cancer:a scoping review[J].Int J Environ Res Public Health,2022,19(3):1769.
[66] 李向阳,李凡,张树泽,等.肿瘤相关性肌少症研究进展[J].解放军医学杂志,2022,47(7):739-744.
LI X Y,LI F,ZHANG S Z,et al.Research progress on tumor-related sarcopenia[J].Med J Chin PLA,2022,47(7):739-744.
[67] PRADO C M,PURCELL S A,LAVIANO A.Nutrition interventions to treat low muscle mass in cancer[J].J Cachexia Sarcopenia Muscle,2020,11(2):366-380.
[68] MUSCARITOLI M,ARENDS J,BACHMANN P,et al.ESPEN practical guideline:clinical nutrition in cancer[J].Clin Nutr,2021,40(5):2898-2913.
[69] MAZZUCA F,ROBERTO M,ARRIVI G,et al.Clinical impact of highly purified,whey proteins in patients affected with colorectal cancer undergoing chemotherapy:preliminary results of a placebo-controlled study[J].Integr Cancer Ther,2019,18:1534735419866920.

相似文献/References:

[1]沈岸.黑默症[J].新乡医学院学报,1986,3(01):089.
[2]戴鼎铎,阎玉兰.老年人的输液问题[J].新乡医学院学报,1987,4(01):075.
[3]赵梅,范素莲.老年肺结核268例临床分析[J].新乡医学院学报,1996,13(03):262.
[4]李万里,张合喜 田玉慧,张志生,等.老年人尿钙氟锰镁和羟脯氨酸与骨密度的关系[J].新乡医学院学报,2000,17(03):153.
[5]张建国. 师桂琴. 喻滔涛.老年人医院下呼吸道感染69例分析[J].新乡医学院学报,2001,18(02):122.
[6]中素芳,扬秀萍,扬君.老年妇科肿瘤的围手术期临床处理[J].新乡医学院学报,2001,18(05):357.
[7]张红旭,安运卿,王 斌,等.老年肝炎肝硬化95例回顾性分析[J].新乡医学院学报,2002,19(03):198.
[8]王云溪,夏玉红.老年人肝炎后肝硬化170例分析[J].新乡医学院学报,2002,19(04):328.
[9]孙丽华,陈玲玲.退休职工514例高血压高血糖高脂血症患病率调查[J].新乡医学院学报,2005,22(02):151.
[10]王素民,张艾青.老年性退行性心脏瓣膜病42例误诊分析 [J].新乡医学院学报,2006,23(02):000.

更新日期/Last Update: 2023-12-05